Literature DB >> 8821095

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.

J R MacDougall1, L M Matrisian.   

Abstract

The malignant progression of tumors is driven by the expression of oncogenes and loss of expression of tumor suppressor genes; factors that are intrinsic to cancer cells. The phenotypic changes brought about by the gain or loss of expression of oncogenes and tumor suppressor genes lead to the acquisition of malignant traits, namely, the ability to invade into and grow in ectopic tissue environments. Recently, however, focus in cancer research has widened from the cancer cell to include the surrounding tumor stroma as an integral player in the process of tumor progression. One of the areas in cancer research contributing to this enhanced appreciation of stromal involvement in tumor progression and metastasis is that of matrix metalloproteinases (MMPs). This review provides an overview of the characteristics of MMPs and discusses their role in the progression and metastasis of tumors. Initially, attention will focus on the regulation of MMPs in tumor cells but will switch to discourse on stromal expression of MMPs in tumors and speculation on the functional consequences of stromal expression of MMPs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821095     DOI: 10.1007/bf00690603

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  82 in total

1.  Collagenolytic activity in amphibian tissues: a tissue culture assay.

Authors:  J GROSS; C M LAPIERE
Journal:  Proc Natl Acad Sci U S A       Date:  1962-06-15       Impact factor: 11.205

2.  Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape.

Authors:  J R MacDougall; R S Kerbel
Journal:  Exp Cell Res       Date:  1995-06       Impact factor: 3.905

3.  Expression of metalloproteinase genes in human prostate cancer.

Authors:  M S Pajouh; R B Nagle; R Breathnach; J S Finch; M K Brawer; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.

Authors:  H Kataoka; R DeCastro; S Zucker; C Biswas
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

5.  The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse.

Authors:  C L Wilson; K J Heppner; L A Rudolph; L M Matrisian
Journal:  Mol Biol Cell       Date:  1995-07       Impact factor: 4.138

6.  Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.

Authors:  W C Powell; J D Knox; M Navre; T M Grogan; J Kittelson; R B Nagle; G T Bowden
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

7.  Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.

Authors:  M D Johnson; H R Kim; L Chesler; G Tsao-Wu; N Bouck; P J Polverini
Journal:  J Cell Physiol       Date:  1994-07       Impact factor: 6.384

8.  Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth.

Authors:  S Koop; R Khokha; E E Schmidt; I C MacDonald; V L Morris; A F Chambers; A C Groom
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

9.  Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium.

Authors:  U K Saarialho-Kere; E C Crouch; W C Parks
Journal:  J Invest Dermatol       Date:  1995-08       Impact factor: 8.551

10.  Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.

Authors:  H Yamamoto; F Itoh; Y Hinoda; A Senota; M Yoshimoto; H Nakamura; K Imai; A Yachi
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

View more
  77 in total

1.  Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.

Authors:  P Yuan; V P Marshall; G L Petzold; R A Poorman; B J Stockman
Journal:  J Biomol NMR       Date:  1999-09       Impact factor: 2.835

2.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.

Authors:  E Barbera-Guillem; K F May; J K Nyhus; M B Nelson
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  The role of chemokines and extracellular matrix components in the migration of T lymphocytes into three-dimensional substrata.

Authors:  Jyrki Ivanoff; Toomas Talme; Karl-Gösta Sundqvist
Journal:  Immunology       Date:  2005-01       Impact factor: 7.397

4.  Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.

Authors:  Timothy G K Mant; Daniel Bradford; Dipti M Amin; Jaya Pisupati; Yoshikazu Kambayashi; Yoshitaka Yano; Kazushige Tanaka; Takuko Yamada-Sawada
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

5.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

6.  Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.

Authors:  B C Finzel; E T Baldwin; G L Bryant; G F Hess; J W Wilks; C M Trepod; J E Mott; V P Marshall; G L Petzold; R A Poorman; T J O'Sullivan; H J Schostarez; M A Mitchell
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

7.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

8.  Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.

Authors:  Luis A Alcaraz; Lucia Banci; Ivano Bertini; Francesca Cantini; Antonio Donaire; Leonardo Gonnelli
Journal:  J Biol Inorg Chem       Date:  2007-08-21       Impact factor: 3.358

9.  Solution structures of stromelysin complexed to thiadiazole inhibitors.

Authors:  B J Stockman; D J Waldon; J A Gates; T A Scahill; D A Kloosterman; S A Mizsak; E J Jacobsen; K L Belonga; M A Mitchell; B Mao; J D Petke; L Goodman; E A Powers; S R Ledbetter; P S Kaytes; G Vogeli; V P Marshall; G L Petzold; R A Poorman
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

10.  Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development.

Authors:  N Thomasset; A Lochter; C J Sympson; L R Lund; D R Williams; O Behrendtsen; Z Werb; M J Bissell
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.